Rivian has reversed sharply from last week's highs, falling 9% to $15.73 and erasing a chunk of the month's earlier 20% rally — yet the bears who sat through that entire surge show no sign of booking profits.
The short interest story is consistent with the previous note: SI has barely moved. It edged down just 2.6% on the week to 11.6% of the free float — roughly 142 million shares — after declining less than 1% across the prior two weeks of sharp gains. Shorts survived a 20% rally in late May, a further 20% move in early June, and are now being rewarded by the reversal. The ORTEX short score ticked up to 70.0 from 69.3 a week ago, still firmly in the upper quintile of the broader universe. The lending market offers no pressure to force a change of view: availability is running at 120% — meaning shares available to borrow comfortably exceed outstanding short positions — and borrow costs have actually eased further, dropping 8% on the week to 0.43% APR, a 30-day low. With borrows this cheap and availability this loose, there is no mechanical squeeze building. Options positioning remains muted, too. The put/call ratio is 0.86, just above its 20-day average of 0.84 and well within normal range — barely half a standard deviation above the mean. The 52-week high on that ratio was 1.21, so options traders are not yet reaching for protection in any unusual way.
The Street retains a broadly constructive bias, but with visible caveats. Needham reiterated its Buy rating and $23 target as recently as June 10, and TD Cowen held at Buy/$20 a week earlier — both well above the current price. DA Davidson, by contrast, is at Neutral with a $15 target, essentially calling the stock fairly valued here. The mean analyst target across the coverage group is $18.15, implying about 15% upside from current levels, which positions bulls as expecting a recovery but not a dramatic re-rating. The factor scores underline the tension: the short score ranks in just the 6th percentile of the universe (meaning heavier short positioning than 94% of peers), while EPS momentum scores sit at the 20th and 21st percentile for 30- and 90-day windows respectively — persistent fundamental weakness underpinning the bearish stance. The bull case rests on the Volkswagen partnership, R2 production ramp, and longer-term autonomy optionality; the bear case centres on the lack of profitability, cash burn, and execution risk on delivery targets.
The ownership picture adds one layer worth watching. Porsche Automobil Holding is the largest institutional shareholder at 16.4% and added more than 62 million shares in the last reported quarter — a significant commitment from a strategic partner. Amazon holds 12.4% and has been static. Renaissance Technologies, notably, trimmed by 5.5 million shares in Q1. On the insider side, both CEO Robert Scaringe and CFO Claire McDonough have been selling modest amounts through May and into early June, though at low significance scores. The trades appear routine rather than a directional signal, but the cadence — multiple small lots from the two most senior insiders — is worth noting heading into a print.
Rivian reports Q1 results on June 22. The last earnings reaction was notably negative: the stock fell 6.5% on the day and 11.7% over the following five days after the April 30 print. The note due in 12 days is therefore less about whether the EV thesis is intact and more about whether Scaringe can offer production guidance that gives bulls something concrete to build a recovery narrative around — with 11.6% of the float still positioned against him.
See the live data behind this article on ORTEX.
Open RIVN on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
